Non-tuberculous mycobacterial infections

References

• September SM, Brozel VS, Venter SN. Diversity of non-tuberculoid Mycobacterium species in biofilms of urban and semi-urban drinking water distribution systems. Appl Environ Microbiol 2004; 70: 7571–3
   PubMed Web of Science ®Google Scholar
• Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004; 17: 413–33
   PubMed Web of Science ®Google Scholar
• Solomon JM, Leung GS, Isberg RR. Intracellular replication of Mycobacterium marinum within Dictyostelium discoideum: efficient replication in the absence of host coronin. Infect Immun 2003; 71: 3578–86
   PubMed Web of Science ®Google Scholar
• Aksamit TR. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 2002; 23: 643–53
   PubMedGoogle Scholar
• Olivier, KN, for the NTM in CF study group. The natural history of non-tuberculous mycobacteria in patients with cystic fibrosis. Pediatr Resp Rev 2004;5:213–6.
   Google Scholar
• Jones D, Havlir DV. Non-tuberculous mycobacteria in the HIV infected patient. Clin Chest Med. 2002; 23: 665–74
   PubMed Web of Science ®Google Scholar
• Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial disease in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001; 1: 503–11
   PubMed Web of Science ®Google Scholar
• Phillips MS, von Reyn CF. Nosocomial infections due to non-tuberculous mycobacteria. Clin Infect Dis 2001; 15: 1363–74
   Google Scholar
• Tiwari TS, Ray B, Jost KC, Jr, Rathod MK, Zhang Y., Brown-Elliot BA., et al. Forty y of disinfectant failure: outbreak of post-injection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis 2003; 15: 954–62
   Google Scholar
• Wallace RJ, Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by non-tuberculous mycobacteria. Annu Rev Microbiol 1998; 52: 453–90
   PubMed Web of Science ®Google Scholar
• Raju B, Schluger NW. Significance of respiratory isolates of Mycobacterium avium complex in HIV-positive and HIV-negative patients. Int J Infec Dis 2000; 4: 134–9
   PubMedGoogle Scholar
• Thomsen VO, Andersen AB, Miorner H. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 2002; 34: 648–53
   PubMed Web of Science ®Google Scholar
• Wolinsky E. Non-tuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119: 107–59
   PubMed Web of Science ®Google Scholar
• Wayne L, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5: 1–25
   PubMed Web of Science ®Google Scholar
• Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16: 319–54
   PubMed Web of Science ®Google Scholar
• Brown-Elliott BA, Griffith DE, Wallace J, Jr. Newly described or emerging human species of non-tuberculous mycobacteria. Infect Dis Clin North Am 2002; 16: 187–220
   PubMed Web of Science ®Google Scholar
• List of validly published names of mycobacteria. 2005. www.bactrio.cict.fr.
   Google Scholar
• Vincent V, Brown-Elliott B, Jost KC, Jr, Wallace RJ, Jr. Mycobacterium: phenotypic and genotypic identification. Manual of Clinical of Microbiology8th edn, PR Murray. American Society for Microbiology, Washington, DC 2003; 560–84
   Google Scholar
• American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:1–25.
   PubMed Web of Science ®Google Scholar
• Subcomittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint tuberculosis committee Guidelines 1999. Thorax 2000;55:210–8.
   PubMedGoogle Scholar
• Iseman MD. Medical management of pulmonary disease caused by Mycobacterium avium complex. Clin Chest Med 2002; 23: 633–41
   PubMedGoogle Scholar
• Wagner D, Young LS. Non-tuberculous mycobacterial infections: a clinical review. Infection 2003; 31: 257–70
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N. Pneumectomy for non-tuberculous mycobacterial infections. Ann Thoracic Surg 2004; 78: 399–403
   PubMed Web of Science ®Google Scholar
• Kline S, Cameron S, Streifel A, Yakrus MA, Kairis F., Peacock K., et al. An outbreak of bacteraemias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 2004; 25: 1042–9
   PubMed Web of Science ®Google Scholar
• Primm TP, Lucero CA, Falkinham III, Jr. Health impacts of environmental mycobacteria. Clin Microbiol Rev 2004; 17: 98–106
   PubMed Web of Science ®Google Scholar
• Heurlin N, Petrini B. Treatment of non-tuberculous mycobacterial infections in patients without AIDS. Scand J Infect Dis 1993; 25: 619–23
   PubMed Web of Science ®Google Scholar
• Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004; 126: 566–81
   PubMed Web of Science ®Google Scholar
• Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M., Fauvill-Dufaux M., et al. Spanish Group for Non-Tuberculosis Mycobacteria. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004; 8: 1186–93
   PubMed Web of Science ®Google Scholar
• Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS., Kim JW. NRAMP1 gene polymorphism and susceptibility to non-tuberculous mycobacterial lung diseases. Chest 2005; 128: 94–101
   PubMedGoogle Scholar
• Hjelte L, Petrini B, Kallenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990; 45: 397–400
   PubMedGoogle Scholar
• Ebert DL, Olivier KN. Non-tuberculous mycobacteria in the setting of cystic fibrosis. Clin Chest Med 2002; 23: 655–63
   PubMedGoogle Scholar
• Slutsky AM, Arbeit RD, Barber TW, Rich J, Von Reyn CF., Pieciak W., et al. Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J Clin Microbiol 1994; 32: 1773–8
   PubMedGoogle Scholar
• Wallace RJ, Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998; 158: 1235–44
   PubMed Web of Science ®Google Scholar
• El Amin NM, Hanson HS, Pettersson B, Petrini B, Von Stedingk LV. Identification of non-tuberculous mycobacteria: 16S rRNA gene sequence analysis vs conventional methods. Scand J Infect Dis 2000; 32: 47–50
   PubMedGoogle Scholar
• Springer B, Böttger E, Kirchner P, Wallace JR, Jr. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterum mucogenicum sp.nov. Int J Systemat Bacteriol 1995; 45: 262–7
   PubMedGoogle Scholar
• Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003; 41: 5355–65
   PubMedGoogle Scholar
• Schluger NW, Kinney D, Harkin TJ, Rom WN. Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis. Chest 1994; 105: 1116–21
   PubMedGoogle Scholar
• Fegou E, Jelastopulu E, Sevdali M, Anastassiou ED, Dimitracopoulos G, Spiliopoulou I. Sensitivity of the Cobas Amplicor system for detection of Mycobacterium tuberculosis in respiratory and extrapulmonary specimens. Clin Microbiol Infect 2005; 11: 593–6
   PubMedGoogle Scholar
• Azov AG, Koch J, Hamilton-Dutoit SJ. Improved diagnosis of mycobacterial infections in formalin-fixed and paraffin-embedded sections with nested polymerase chain reaction. APMIS 2005; 113: 586–93
   PubMedGoogle Scholar
• Rodrgues Vde CF., Queiroz Mello FC., Ribeiro MO., Fonseca L., Kritski AL., Rossetti ML., Zah A. Detection of Mycobacterium avium in blood samples of patients with AIDS by using PCR. J Clin Microbiol 2002; 40: 2297–9
   PubMedGoogle Scholar
• Marsh BJ, San Vicente J, Von Reyn CF. Utility of dual skin tests to evaluate tuberculin skin test reactions of 10 to 14 mm in healthcare workers. Infect Control Hosp Epidemiol 2003; 24: 821–4
   PubMedGoogle Scholar
• Ferrara G, Losi M, Meacci M, Meccugni B, Piro R., Roversi P., et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculous infection. Am J Respir Crit Care Med 2005; 172: 631–5
   PubMed Web of Science ®Google Scholar
• Wong PC. Management of tuberculous pleuritis: can we do better?. Respirology 2005; 10: 144–8
   PubMed Web of Science ®Google Scholar
• Hoffner SE, Henriques B, Petrini B, Kallenius G. Mycobacterium malmoense: an easily missed pathogen. J Clin Microbiol 1991; 29: 2673–4
   PubMedGoogle Scholar
• Angeby KA, Werngren J, Toro JC, Hedstrom G, Petrini B, Hoffner SE. Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect 2003; 9: 1148–52
   PubMed Web of Science ®Google Scholar
• Kirschner P, Bottger EC. Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol 1998; 101: 349–61
   PubMedGoogle Scholar
• Chemlal K, Portaels F. Molecular diagnosis of non-tuberculous mycobacteria. Curr Opin Infect Dis 2003; 16: 77–83
   PubMed Web of Science ®Google Scholar
• Brunello F, Ligozzi M, Cristelli E, Bonora S, Tortoli E, Fontana R. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol 2001; 39: 2799–2806
   PubMedGoogle Scholar
• Sarkola A, Mäkinen J, Marjamäki M, Marttila HJ, Viljanen MK, Soini H. Prospective evaluation of the GenoType assay for routine identification of mycobacteria. Eur J Microbiol Infect Dis 2004; 23: 642–5
   PubMed Web of Science ®Google Scholar
• Suffys PN, da Silva Rocha A, de Oliveira M, Campos CE, Barrelo RM, Poriacls F, et al. Rapid identification of mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol 2001; 39: 4477–82
   PubMedGoogle Scholar
• Lebrun L, Weill FX, Lafendi L, Houriez F, Casanova F, Gulterrez MC, et al. Use of the INNO-LiPA-MYCOBACTERIA assay (version 2) for identification of Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex isolates. J Clin Microbiol 2005; 43: 2567–74
   PubMedGoogle Scholar
• Raju B, Schluger NW. Significance of respiratory isolates of Mycobacterium avium complex in HIV-positive and HIV-negative patients. Int J Infect Dis 2000; 4: 134–9
   PubMedGoogle Scholar
• Inderlied CB, Pfyffer G. Susceptibility test methods: Mycobacteria. Manual of Clinical Microbiology8th edn, PR Murray. American Society for Microbiology, Washington, DC 2003; 1149–77
   Google Scholar
• Woods GL. Susceptibility testing for mycobacteria. Clin Infect Dis 2000; 31: 1209–15
   PubMed Web of Science ®Google Scholar
• Heginbothom ML. The relationship between in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment. Int J Tuberc Lung Dis 2001; 5: 539–45
   PubMed Web of Science ®Google Scholar
• Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Boulet B, Plaunt M, et al. Multiple reproducibility for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 2000; 38: 65–61
   Google Scholar
• Wallace RJ, Jr, Brown-Elliott A, Christ CJ, Mann L, Wilson R W. Comparison of in vitro activity of the glycycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of non-tuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46: 3164–7
   PubMed Web of Science ®Google Scholar
• Brown-Elliott BA, Wallace RJ, Jr, Blinkhorn R, Mann LB. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001; 33: 1433–4
   PubMed Web of Science ®Google Scholar
• Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002; 23: 623–32
   PubMedGoogle Scholar
• Samuels LE, Sharma S, Morris RJ, Solomon MP, Granick MS, Wood CA, et al. Mycobacterium fortuitum infection of the sternum. Review of the literature and case illustration. Arch Surg 1996; 13: 1344–6
   Google Scholar
• Winthrop KL, Albridge K, South D, Albrecht P, Abrams M, Samuel MC, et al. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis 2004; 38: 38–44
   PubMed Web of Science ®Google Scholar
• Vugia DJ, Jang Y, Zizek C, Ely J, Winthrop KL, Desmond E. Mycobacteria in nail salon whirlpool footbaths, California. Emerg Infect Dis 2005; 11: 616–8
   PubMed Web of Science ®Google Scholar
• Hofling-Lima AL, de Freitas D, Sampaio JL, Leao SC, Contarini P. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 2005; 24: 730–4
   PubMedGoogle Scholar
• Schinsky MF, McNeil MM, Whitney AM, Steigerwalt AG, Lashere BA, Floyd MM, et al. Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int J Syst Evol Microbiol 2000; 502: 575–81
   Google Scholar
• Woods GL. Mycobacterial susceptibility testing and reporting: when, how and what to test. Clinical Microbiological Newsletter 2005; 27: 67–72
   Google Scholar
• National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes. M 24 –TA. NCCLS, WaynePa. 2003.
   Google Scholar
• Koivula T, Cristea-Fernstrom M, Chryssanthou E, Petrini B, Kallenius G. Genetic diversity in clinical isolates of Mycobacterium avium complex from Guinea-Bissau, West Africa. Microbes Infect 2004; 6: 1320–5
   PubMed Web of Science ®Google Scholar
• Forslöw U, Geborek A, Hjelte L, Petrini B, Heurlin N. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta Paediatr 2003; 92: 910–5
   PubMedGoogle Scholar
• Pierre-Augidier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offred C, Vutien H, et al. Age-related prevalence and distribution of non-tuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005; 43: 3467–70
   PubMedGoogle Scholar
• Kalayjian RC, Toossi Z, Tomashefski JF, Jr, Carey JT, Ross JA, Tomford JW, et al. Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1995; 20: 1186–94
   PubMed Web of Science ®Google Scholar
• Petrofsky M, Bermudez LE. CD4+ T-cells but not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route. Infect Immun 2005; 73: 2621–7
   PubMedGoogle Scholar
• Julander I, Hoffner S, Petrini B, Östlund L. Multiple serovars of Mycobacterium avium complex in patients with AIDS. Acat Pathol Microbiol Scand 1996; 104: 318–20
   Google Scholar
• Ohkusu K, Bermudez LE, Nash KA, MacGregor RR, Inderlied CB. Differential virulence of Mycobacterium avium strains isolated from HIV-infected patients with disseminated M. avium-complex disease. J Infect Dis 2004; 190: 1347–54
   PubMedGoogle Scholar
• Wallace RJ, Jr, Brown BN, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am J Crit Care Med 1996; 153: 1766–72
   Google Scholar
• Griffith DE, Brown BA, Girard WM, Murphy DT, Wallace RJ, Jr. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 983–9
   PubMed Web of Science ®Google Scholar
• Kallenius G, Svenson SB, Hoffner SE. Ethambutol: a key for Mycobacterium avium complex chemotherapy?. Am Rev Respir Dis 1989; 140: 264
   PubMed Web of Science ®Google Scholar
• Wallace RJ, Jr, Brown BA, Griffith DE, Girard W, Tanaka K. Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampicin or rifabutin for Mycobacterium avium, M. intracellulare infection. J Infect Dis 1995; 171: 7474–50
   Google Scholar
• Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ, Jr. Early results (6 months) with intermittent clarithromycin- including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000; 30: 288–92
   PubMed Web of Science ®Google Scholar
• Burkhardt O, Kohnlein T, Pap T, Welte T. Recurrent tendinitis after treatment with 2 different fluoroquinolones. Scand Infect Dis 2004; 36: 315–6
   PubMed Web of Science ®Google Scholar
• The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium- intracellulare in HIV-negative patients: 5-y follow-up of patients receiving standard treatment. Int J Tuberc Lung Dis 2002;6:628–34.
   PubMedGoogle Scholar
• Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N. Pneumonectomy for non-tuberculous mycobacterial infections. Ann Thorac Surg 2004; 78: 399–403
   PubMed Web of Science ®Google Scholar
• Henry MT, Inamdar L, O'Riordain D, Schweiger M, Watson JP. Non-tuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004; 23: 741–6
   PubMed Web of Science ®Google Scholar
• Chao SS, Loh KS, Tan KK, Chong SM. Tuberculous and non-tuberculous cervical lymphadenitis: a clinical review. Otolaryngol Head Neck Surg 2002; 126: 176–9
   PubMedGoogle Scholar
• Lundberg B, Eriksson M, Petrini B. Complicated course of local mycobacterial infection in an immunocompetent girl. Scand J Infect Dis 1996; 28: 99–100
   PubMed Web of Science ®Google Scholar
• Henriques B, Hoffner SE, Petrini B, Juhlin I, Wahlen P, Kallenius G. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994; 18: 596–600
   PubMed Web of Science ®Google Scholar
• Portaels F, Larsson L, Jenkins PA. Isolation of Mycobacterium malmoense from the environment in Zaire. Tubercle and Lung Disease 1995; 76: 160–2
   PubMedGoogle Scholar
• Research Committee of British Thoracic Society: Pulmonary disease caused by M. malmoense in HIV negative patients: 5-y follow-up of patients receiving standardized treatment. Eur Respir J 2003;21:478–82.
   PubMedGoogle Scholar
• Research committee of the British Thoracic Society. First randomized trial of treatments for pulmonary disease caused by M avium intracellulare, M. malmoense, and M. xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56:167–72.
   PubMed Web of Science ®Google Scholar
• Cummings DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol 2005; 44: 518–20
   PubMedGoogle Scholar
• Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. 63 cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162: 1746–52
   PubMed Web of Science ®Google Scholar
• Conger NG, O'Connell RJ, Laurel VL, Olivier KN, Graviss EA, Willama-Boyer N, et al. Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 2004; 25: 1050–5
   PubMed Web of Science ®Google Scholar
• Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002; 23: 613–21
   PubMedGoogle Scholar
• Piersimoni C, Zitti PG, Nista D, Bornigia S. Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review. Emerg Infect Dis 2003; 9: 399–402
   PubMed Web of Science ®Google Scholar
• Tortoli E, Piersimoni C, Bacosi A, Betti F, Barfoni A, Bonol L, et al. Isolation of the newly described species Mycobacterium celatum from AIDS patients. J Clin Microbiol 1995; 33: 137–40
   PubMed Web of Science ®Google Scholar
• Frisk P, Boman G, Pauksen K, Petrini B, Lonnerholm G. Skin infection caused by Mycobacterium szulgai after allogeneic bone marrow transplantation. Bone Marrow Transplant 2003; 31: 511–3
   PubMedGoogle Scholar
• Rustscheff S, Maroti L, Holberg-Petersen M, Steinbakk M, Hoffner SE. Mycobacterium interjectum: a new pathogen in humans?. Scand J Infect Dis 2000; 32: 569–71
   PubMedGoogle Scholar
• De Baere T, Moerman M, Rigouts L, Dhooge C, Vermeersch H, Verschraegen G, Vaneechoutte M. Mycobacterium interjectum as causative agent of cervical lymphadenitis. J Clin Microbiol 2001; 39: 725–7
   PubMedGoogle Scholar
• Brander E, Janzen E, Huttunen R, Julkunen A, Katila M. Characterization of a distinct group of mycobacteria by biochemical tests and lipid analysis. J Clin Microbiol 1992; 30: 1972–5
   PubMedGoogle Scholar
• Petrini B, Svartengren G, Hoffner SE, Unge G, Widstrom O. Tenosynovitis of the hand caused by Mycobacterium terrae. Eur J Clin Microbiol Infect Dis 1989; 8: 722–4
   PubMedGoogle Scholar
• Christensson B, Olsson B, Arner M, Miorner H. Subcutaneous infection of the hand due to Mycobacterium nonchromogenicum. J Hand Surg (Am) 1993; 18: 130–2
   PubMedGoogle Scholar
• Garofalo R, Chadwick EG, Yogev R. Mycobacterium gordonae bacteraemia in an asymptomatic adolescent with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2003; 22: 569–70
   PubMedGoogle Scholar